Quinazolines for pdk1 inhibition

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 239/94 (2006.01) C07D 401/04 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 403/06 (2006.01) C07D 403/10 (2006.01) C07D 403/12 (2006.01) C07D 403/14 (2006.01) C07D 405/04 (2006.01) C07D 405/12 (2006.01) C07D 405/14 (2006.01) C07D 409/12 (2006.01) C07D 413/04 (2006.01) C07D 413/12 (2006.01)

Patent

CA 2648529

The invention provides quinazoline compounds that are inhibitors of PDKl. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.

La présente invention concerne de nouveaux composés de quinazoline qui sont des inhibiteurs de PDK1. L'invention a également trait à des compositions pharmaceutiques comprenant ces composés ainsi qu'à des procédés de traitement des maladies prolifératives, telles que les cancers, par lesdits composés ou compositions.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Quinazolines for pdk1 inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinazolines for pdk1 inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazolines for pdk1 inhibition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1700176

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.